There are substantial commonalities that underpin the gastrointestinal (GI) functions of both humans and dogs and their responses to diseases and drugs, including cancer and various forms of cancer treatments.
Before we can broadly incorporate these tests into our clinical practice, we need to understand how they work, consider the evidence behind them.
Tyson, a three-month-old French bulldog, had its lower left mandible removed at the Cornell University College of Veterinary Medicine due to a malignant oral tumor
In this session: Craig Clifford, DVM, MS, DACVIM (Oncology), describes the latest in the field of oncology, including a chemotherapy sensitivity assay from Imprimed to help guide drug decisions, a new conditionally approved drug for canine lymphoma called Laverdia CA-1, and the use of the oncoK9 liquid biopsy test from PetDx.
The AI-driven digital imaging platform will be developed to collect, collate, and analyze patient data from the UF College of Veterinary Medicine’s clinical caseload across animal species.
“Some Asian herbs act as chemosensitizers and radiosensitizers; others are chemoprotective and radioprotective. How all these herbs and drugs interact when co-administered remains anybody’s guess.”
The new research is set to evaluate the effectiveness of a novel drug combination tailored to giant-breed dogs diagnosed with osteosarcoma.
This year, approximately six million dogs will be diagnosed with cancer. Although the incidence of canine cancer is nearly three times higher than human cancer, veterinarians have far fewer tools at their disposal to effectively treat their patients.
Improving outcomes for dogs afflicted with a particularly aggressive and fatal type of cancer is the goal of a clinical trial currently underway.
A newly funded study will evaluate the potential of a cancer drug to control tumor growth for dogs with histiocytic sarcoma. The multi-center clinical trial, which is being conducted at Michigan State University (MSU), University of Florida, University of Wisconsin, and …
Morris Animal Foundation’s Golden Retriever Lifetime Study has now reached a milestone with the accrual of 500 cumulative diagnoses of four major cancers in dogs: hemangiosarcoma, lymphoma, high-grade mast cell tumor, and osteosarcoma.
